The customer, a syncardia certified hospital, reported that the patient died on (b)(6) 2020.The customer listed the cause of death as multi-organ system failure with contributing factors to the death of possible antiphospholipid syndrome and that the tah-t did not cause or contribute to the patient death.An autopsy was performed and the tah-t was explanted.No further information has been provided at this time.
|
The customer did not report a device malfunction and attributed the cause of death to multi-organ system failure.The tah-t was explanted following the autopsy and returned to syncardia for evaluation.Visual inspection, valve evaluation, thrombus formation evaluation, and a stroke volume evaluation were performed during the tah-t explant analysis.No anomalies or abnormalities were observed.This issue will be monitored and trended as part of the customer complaint process.Syncardia has completed its investigation and is closing this file.(b)(4) follow-up report 1.
|